Tag: Cobra Pzf
CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...
Positive clinical results from eCOBRA study
CeloNova BioSciences has announced one-year clinical trial results from the eCOBRA post-market s...
Cobra PzF nano-coated stent now being studied with 14-day DAPT in patients at high risk of bleeding
The US FDA has approved the expansion of CeloNova’s ongoing clinical trial of its proprietary Cobra ...
Cobra PzF stent approved for commercial use in the USA
The FDA has approved a nano-coated coronary stent system—CeloNova Biosciences’ Cobra PzF—for use...
